DAG1
DAG1 (dystroglycan 1) encodes dystroglycan, a central component of the dystrophin-glycoprotein complex that links the extracellular matrix to the cytoskeleton in skeletal muscle. It is also known as A3a, 156DAG, AGRNR and DAG. Browse Assay Genie's current range of DAG1 research reagents below, or read on for the biology behind the target.
Dystroglycan, the product of the DAG1 gene, is a central component of the dystrophin-glycoprotein complex. In skeletal muscle this complex links the extracellular matrix with the cytoskeleton, providing a physical connection across the cell membrane. UniProt annotates the protein in several compartments, including the sarcolemma, the basement membrane of the extracellular matrix, the cell membrane, the cytoskeleton, the synapse and the postsynaptic cell membrane, with additional nucleoplasmic and secreted forms recorded.
The DAG1 gene encodes a preproprotein that undergoes O- and N-glycosylation and proteolytic processing to generate alpha and beta subunits. Alternative splicing produces multiple transcript variants, all of which encode the same protein. Researchers working with dystroglycan therefore often need to distinguish the two processed subunits and the glycosylation state of the mature protein, as well as the precursor.
DAG1 was previously named dystroglycan 1 (dystrophin-associated glycoprotein 1), and the aliases A3a, 156DAG, AGRNR and DAG appear in the literature. Certain mutations in the gene are known to cause distinct forms of muscular dystrophy. Dystroglycan also has a role in infection: it acts as a receptor for Lassa virus, lymphocytic choriomeningitis virus glycoprotein and class C New World arenaviruses. It serves as a Schwann cell receptor for Mycobacterium leprae, the causative organism of leprosy, but only in the presence of the G-domain of LAMA2.
Certain DAG1 mutations cause distinct forms of muscular dystrophy, making dystroglycan a focus for studies of muscle disease mechanisms.
Dystroglycan is a core part of the dystrophin-glycoprotein complex that connects the extracellular matrix to the cytoskeleton in skeletal muscle.
The preproprotein is O- and N-glycosylated and proteolytically cleaved into alpha and beta subunits, a useful model for protein maturation.
Dystroglycan is a receptor for Lassa virus, lymphocytic choriomeningitis virus and Mycobacterium leprae in Schwann cells, relevant to infection biology.
DAG1 encodes dystroglycan, a central component of the dystrophin-glycoprotein complex. In skeletal muscle this complex links the extracellular matrix and the cytoskeleton. The protein is also exploited as a receptor by Lassa virus, lymphocytic choriomeningitis virus and Mycobacterium leprae.
DAG1 is also known as A3a, 156DAG, AGRNR and DAG, and was previously named dystrophin-associated glycoprotein 1. The preproprotein is O- and N-glycosylated and proteolytically processed into alpha and beta subunits. Alternative splicing gives transcript variants that all encode the same protein.
Certain DAG1 mutations are known to cause distinct forms of muscular dystrophy. The mouse ortholog is Dag1. Check the datasheet of any product for its validated reactivity before using it in a particular species.
Dystrophin-glycoprotein complex partners and laminin ligands relevant to dystroglycan biology.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q14118; product specifications from Assay Genie datasheets.